Complete Up To Date Information about 3-Nitro / BMD / Clinacox™.
NADA Number: 141-190 | |
| Proprietary Name |
3-Nitro® / BMD® / Clinacox™ |
|---|---|
| Sponsor |
Huvepharma AD |
| Sponsor Address |
33 James Boucher Blvd. Sophia 1407, Bulgaria |
| Ingredients |
Diclazuril Bacitracin Methylene Disalicylate Roxarsone |
| Species |
Chicken, broilers not laying eggs for human consumption |
| Routes of Administration |
Per Os |
| Dose Form |
Medicated feed |
| Drug Form |
Type A Medicated Article |
| Dispensing Status |
OTC |
| Withdrawal Time |
Chicken: 5 days before slaughter. |
|
Dosage Amount, Indications & Limitations |
558.198 Diclazuril. Specifications: Type A medicated article containing 0.2 percent diclazuril. Broiler chickens: Amount Diclazuril 0.91 grams per ton feed in combination with bacitracin methylene disalicylate 50 grams per ton of feed plus roxarsone 22.7 to 45.4 grams per ton. Indications: For the prevention of necrotic enteritis caused or complicated by Clostridium species or other organisms susceptible to bacitracin, for improved rate of weight gain, for improved feed efficiency and improved pigmentation. Limitations: Use as sole source of organic arsenic. Drug overdose or lack of water may result in leg weakness. Not for use in hens producing eggs for human consumption. Withdrawal 5 days before slaughter. Amount Diclazuril 0.91 grams per ton feed in combination with bacitracin methylene disalicylate 100 to 200 grams per ton of feed plus roxarsone 22.7 to 45.4 grams per ton. Indications: As an aid in the control of necrotic enteritis caused or complicated by Clostridium species or other organisms susceptible to bacitracin, for improved rate of weight gain, for improved feed efficiency and improved pigmentation. Limitations: Feed throughout growing period. Start at first signs of clinical disease; vary dosage of bacitracin based on severity of infection; administer continuously for 5 to 7 days or as long as clinical signs persist. Then reduce bacitracin to prevention level (50 grams per ton). Use as sole source of organic arsenic. Drug overdose or lack of water may result in leg weakness. Not for use in hens producing eggs for human consumption. Withdrawal 5 days before slaughter. |
| Tolerances |
Tolerances for total residues of combined arsenic (calculated as Arsenic) in food are established as follows: a. Chickens and turkeys (edible tissues): (1) 0.5 part per million in uncooked muscle tissue. (2) 2 parts per million in uncooked edible by-products. b. Chicken and turkey eggs: 0.5 part per million c. Swine (edible tissues): (1) 2 parts per million in uncooked liver and kidney. (2) 0.5 part per million in uncooked muscle tissue and by-products other than liver and kidney. Chickens: Liver. Tolerances are established for residues of parent diclazuril (the marker residue) is 3 parts per million Muscle. The tolerance for parent diclazulril (the marker residue) is 0.5 parts per million. Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 part per million. Turkeys: Liver. Tolerances are established for residues of parent diclazuril (the marker residue) is 3 parts per million Muscle. The tolerance for parent diclazulril (the marker residue) is 0.5 parts per million. Skin/fat. The tolerance for parent diclazuril (the marker residue) is 1 part per million. The tolerance for residues of bacitracin from zinc bacitracin or bacitracin methylene disalicylate in uncooked edible tissues of cattle, swine, chickens, turkeys, pheasants, and quail, and in milk and eggs is 0.5 part per million |